Genmab raised its full-year revenue and profit guidance on Thursday, driven by stronger-than-expected royalties from key ...

There is no certainty that the buyout will come to pass, according to The Financial Times, which first reported the rumors.

August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025 Highlights Epcoritamab advancing to earlier lines of therapy with the submission of a sBLA to the FDA for epco ...

Today, the regulator revealed FDA PreCheck, which introduces a two-phase approach to getting approval for new production ...

Chronic spontaneous urticaria places a heavier burden on patients than atopic dermatitis and psoriasis, leading to a worse ...

A new American Heart Association initiative is working to increase screening for lipoprotein(a) (Lp[a]) at community health ...

Cancer vaccine experts are worried that if the Trump administration takes a hostile posture towards mRNA broadly, cancer ...

Switzerland plans to continue negotiating with the US to lower tariffs from the 39% that kicked in on Thursday and will ...

Yet, within the past 24 hours, Trump has doubled the tariffs on India to 50%, imposed an additional 15% on Japan, announced a ...

--Novartis made a takeover approach for Avidity Biosciences, a biotechnology company that specializes in rare diseases with a market value of $5.8 billion, the Financial Times reports, citing unnamed ...

Millions of people are alive today because of leukemia therapies that arose from UC research, including retired Army Major ...

The US Food and Drug Administration approved the revised label for inclisiran, a small interfering RNA that reduces the ...